{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:15:51Z","timestamp":1648851351187},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.semerg.2013.10.006","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T21:04:25Z","timestamp":1391202265000},"page":"247-253","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relaci\u00f3n entre el f\u00e1rmaco antihipertensivo utilizado y la aparici\u00f3n de fibrilaci\u00f3n auricular en los pacientes hipertensos de un centro de Atenci\u00f3n Primaria"],"prefix":"10.1016","volume":"40","author":[{"given":"A.\u00c1.","family":"Mena-Villalba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Lend\u00ednez-de la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Cubero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Monsalvo-Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Guti\u00e9rrez-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda-Alfons\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2013.10.006_bib0005","doi-asserted-by":"crossref","first-page":"e941","DOI":"10.1161\/CIRCULATIONAHA.112.112920","article-title":"Novel risk factors for atrial fibrillation: Useful for risk prediction and clinical decision making?","volume":"125","author":"Rienstra","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2013.10.006_bib0010","first-page":"437","article-title":"Risk factors for atrial fibrillation: Not always severe heart disease, not always so \u2018lonely\u2019","volume":"17","author":"Rosiak","year":"2010","journal-title":"Cardiol J"},{"key":"10.1016\/j.semerg.2013.10.006_bib0015","first-page":"346","article-title":"Epidemiology of atrial fibrillation","volume":"139","author":"Conen","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.semerg.2013.10.006_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/HJH.0b013e32834f03bf","article-title":"Hypertension and atrial fibrillation: Diagnostic approach, prevention and treatment. Position paper of the Working Group \u2018Hypertension Arrhythmias and Thrombosis\u2019 of the European Society of Hypertension","volume":"30","author":"Manolis","year":"2012","journal-title":"J Hypertension"},{"key":"10.1016\/j.semerg.2013.10.006_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.acvd.2010.11.012","article-title":"Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data","volume":"104","author":"Charlemagne","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"issue":"Supl 1","key":"10.1016\/j.semerg.2013.10.006_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1138-3593(13)74375-2","article-title":"Aspectos epidemiol\u00f3gicos y diagn\u00f3sticos de la fibrilaci\u00f3n auricular","volume":"39","author":"Llisterri Caro","year":"2013","journal-title":"Semergen"},{"key":"10.1016\/j.semerg.2013.10.006_bib0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1138-3593(05)72947-6","article-title":"Estudio de prevalencia de la fibrilaci\u00f3n auricular en la poblaci\u00f3n de 65 a\u00f1os o m\u00e1s. Validez de la toma de pulso radial como cribado de fibrilaci\u00f3n auricular","volume":"31","author":"Robledo-Mart\u00edn","year":"2005","journal-title":"Semergen"},{"key":"10.1016\/j.semerg.2013.10.006_bib0065","first-page":"1483.e1","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica para el manejo de la fibrilaci\u00f3n auricular","volume":"63","author":"Camm","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.semerg.2013.10.006_bib0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0828-282X(06)70265-3","article-title":"Stroke prevention in patients with atrial fibrillation: The diagnosis and management of hypertension by specialists","volume":"22","author":"Healey","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.semerg.2013.10.006_bib0075","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/STROKEAHA.110.589531","article-title":"Blood pressure variability and risk of new-onset atrial fibrillation: A systematic review of randomized trials of antihypertensive drugs","volume":"41","author":"Webb","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.semerg.2013.10.006_bib0080","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.semerg.2013.10.006_bib0085","unstructured":"National Institute for Health and Care Excellence. Hypertension: Clinical management of primary hypertension in adults. NICE clinical guidelines, CG127. Issued: August 2011 [consultado 12 Ene 2012]. Disponible en: http:\/\/publications.nice.org.uk\/hypertension-cg127"},{"key":"10.1016\/j.semerg.2013.10.006_bib0090","first-page":"235","article-title":"Consensus statement for the prevention of vascular disease","volume":"33","year":"2004","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.semerg.2013.10.006_bib0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0300-8932(10)70206-2","article-title":"Prevalencia de fibrilaci\u00f3n auricular y uso de f\u00e1rmacos antitromb\u00f3ticos en el paciente hipertenso\u226565 a\u00f1os","volume":"63","author":"Morillas","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.semerg.2013.10.006_bib0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11886-009-0062-4","article-title":"Hypertension and atrial fibrillation","volume":"11","author":"Go","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.semerg.2013.10.006_bib0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin ii receptor blockade: The VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.semerg.2013.10.006_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-152-2-201001190-00005","article-title":"Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: A nested case-control study","volume":"152","author":"Schaer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2013.10.006_bib0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ajh.2009.33","article-title":"Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population","volume":"22","author":"Heckbert","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semerg.2013.10.006_bib0105","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting blockers angiotensin enzyme inhibitors: A meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semerg.2013.10.006_bib0110","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1540-8167.2010.01792.x","article-title":"The effects of rate and rhythm control in blood pressure and use of antihypertensive drugs in patients with atrial fibrillation and hypertension included in the AFFIRM trial","volume":"21","author":"Masood","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.semerg.2013.10.006_bib0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/HCO.0b013e32833a8828","article-title":"ALLHAT: Still providing correct answers after 7 years","volume":"25","author":"Einhorn","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.semerg.2013.10.006_bib0050","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ajh.2008.248","article-title":"Blood pressure control and risk of incident atrial fibrillation","volume":"21","author":"Thomas","year":"2008","journal-title":"Am J Hypertens"}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359313002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359313002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T00:57:43Z","timestamp":1538873863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359313002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1138359313002840"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2013.10.006","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relaci\u00f3n entre el f\u00e1rmaco antihipertensivo utilizado y la aparici\u00f3n de fibrilaci\u00f3n auricular en los pacientes hipertensos de un centro de Atenci\u00f3n Primaria","name":"articletitle","label":"Article Title"},{"value":"SEMERGEN - Medicina de Familia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2013.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}